Appointment of Members of Senior Executive Service Performance Review Board, 43608 [2020-15491]

Download as PDF 43608 Federal Register / Vol. 85, No. 138 / Friday, July 17, 2020 / Notices Dated: July 14, 2020. Stefanie Davis, Senior Assistant General Counsel. Engagement —Deliberations on any Findings and Recommendations —Other UAG Business and Work Plan Schedule; Closing Remarks In accordance with 41 CFR parts 101– 6 and 102–3, Federal Advisory Committee Management; Final Rule, Section 102–3.150(b), this meeting is being held with less than 15 calendar days’ notice to accommodate the scheduling priorities of the key participants. [FR Doc. 2020–15493 Filed 7–16–20; 8:45 am] BILLING CODE 7050–01–P NATIONAL AERONAUTICS AND SPACE ADMINISTRATION [Notice: (20–062)] National Space Council Users’ Advisory Group; Meeting Patricia Rausch, Advisory Committee Management Officer, National Aeronautics and Space Administration. National Aeronautics and Space Administration (NASA). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, as amended, the National Aeronautics and Space Administration (NASA) announces a meeting of the National Space Council Users’ Advisory Group (UAG). This will be the fifth meeting of the UAG. DATES: Thursday, July 30, 2020, from 10:00 a.m.–1:00 p.m., Eastern Time. ADDRESSES: Virtual meeting via dial-in teleconference and WebEx only. FOR FURTHER INFORMATION CONTACT: As noted above, this meeting will be available telephonically and by WebEx only. You must use a touch-tone phone to participate in this meeting. Any interested person may dial the USA tollfree conference call number 1–844–467– 4685 or toll number 1–720–259–7012, passcode 106724#, to participate in this meeting by telephone. The WebEx link is https://nasaenterprise.webex.com/; the meeting number is 199 379 7435, and password is tHiRkEk@574. To help facilitate public input in this all-virtual event, we invite appropriate written submissions to the UAG public email address at: contact@ spacecounciluag.org, in addition to verbal input during the event. The agenda for the meeting will include the following: —Opening Remarks and Meeting Objectives by UAG Chair —Expert Presentation on ‘‘Contributions of Historically Black Colleges and Universities (HBCUs) to Science, Engineering, and the Space Workforce’’ —Reports and Updates from UAG Subcommittees: • Exploration and Discovery • National Security Space • Technology and Innovation • Economic Development/Industrial Base • Outreach and Education • Space Policy and International khammond on DSKJM1Z7X2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 18:12 Jul 16, 2020 Jkt 250001 [FR Doc. 2020–15510 Filed 7–16–20; 8:45 am] BILLING CODE 7510–13–P EXECUTIVE OFFICE OF THE PRESIDENT Office of National Drug Control Policy & DATE: Wednesday, July 22, 2020 from 2:30–3:30 p.m. EDT. PLACE: This meeting will be held by teleconference through the National Science Foundation. STATUS: Closed. MATTERS TO BE CONSIDERED: The agenda of the teleconference is: Committee Chair’s Opening Remarks; Discussion of NSF’s Fiscal Year 2022 budget submission to the Office of Management and Budget. CONTACT PERSON FOR MORE INFORMATION: Point of contact for this meeting is: Chris Blair, telephone: (703) 292–7000. Meeting information and updates may be found at https://www.nsf.gov/nsb/ meetings/notices.jsp#sunshine. Please refer to the National Science Board website www.nsf.gov/nsb for general information. TIME Chris Blair, Executive Assistant to the National Science Board Office. [FR Doc. 2020–15613 Filed 7–15–20; 11:15 am] Appointment of Members of Senior Executive Service Performance Review Board BILLING CODE 7555–01–P Office of National Drug Control Policy (ONDCP). ACTION: Notice of appointments. NUCLEAR REGULATORY COMMISSION AGENCY: The following persons have been appointed to the ONDCP Senior Executive Service Performance Review Board: Ms. Martha Gagne´ (as Chair), Mr. Kemp Chester, Mr. Eric Talbot, and Dr. Terry Zobeck. FOR FURTHER INFORMATION CONTACT: Please direct any questions to Michael Passante, Acting General Counsel, (202) 395–6709, Office of National Drug Control Policy, Executive Office of the President, Washington, DC 20503. SUMMARY: [NRC–2020–0001] Sunshine Act Meetings Weeks of July 20, 27, August 3, 10, 17, 24, 31, September 7, 14, 21, 28, October 5, 12, 19, 2020. PLACE: Commissioners’ Conference Room, 11555 Rockville Pike, Rockville, Maryland. STATUS: Public. TIME AND DATE: Week of July 20, 2020 Dated: July 14, 2020. Michael Passante, Acting General Counsel. There are no meetings scheduled for the week of July 20, 2020. [FR Doc. 2020–15491 Filed 7–16–20; 8:45 am] There are no meetings scheduled for the week of July 27, 2020. Week of July 27, 2020—Tentative BILLING CODE 3280–F5–P Week of August 3, 2020—Tentative NATIONAL SCIENCE FOUNDATION There are no meetings scheduled for the week of August 3, 2020. Sunshine Act Meeting Week of August 10, 2020—Tentative The National Science Board’s Strategy Committee, pursuant to NSF regulations (45 CFR part 614), the National Science Foundation Act, as amended (42 U.S.C. 1862n–5), and the Government in the Sunshine Act (5 U.S.C. 552b), hereby gives notice of the scheduling of a teleconference for the transaction of National Science Board business, as follows: There are no meetings scheduled for the week of August 10, 2020. PO 00000 Frm 00077 Fmt 4703 Sfmt 4703 Week of August 17, 2020—Tentative There are no meetings scheduled for the week of August 17, 2020. Week of August 24, 2020—Tentative There are no meetings scheduled for the week of August 24, 2020. E:\FR\FM\17JYN1.SGM 17JYN1

Agencies

[Federal Register Volume 85, Number 138 (Friday, July 17, 2020)]
[Notices]
[Page 43608]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-15491]


=======================================================================
-----------------------------------------------------------------------

EXECUTIVE OFFICE OF THE PRESIDENT

Office of National Drug Control Policy


Appointment of Members of Senior Executive Service Performance 
Review Board

AGENCY: Office of National Drug Control Policy (ONDCP).

ACTION: Notice of appointments.

-----------------------------------------------------------------------

SUMMARY: The following persons have been appointed to the ONDCP Senior 
Executive Service Performance Review Board: Ms. Martha Gagn[eacute] (as 
Chair), Mr. Kemp Chester, Mr. Eric Talbot, and Dr. Terry Zobeck.

FOR FURTHER INFORMATION CONTACT: Please direct any questions to Michael 
Passante, Acting General Counsel, (202) 395-6709, Office of National 
Drug Control Policy, Executive Office of the President, Washington, DC 
20503.

    Dated: July 14, 2020.
Michael Passante,
Acting General Counsel.
[FR Doc. 2020-15491 Filed 7-16-20; 8:45 am]
BILLING CODE 3280-F5-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.